$Azitra (AZTR.US)$ NEWS Azitra Presents Preclinical Data Fro...
NEWS
Azitra Presents Preclinical Data From ATR-04 At Society Of Investigative Dermatology Annual Meeting
Benzinga· 37 mins ago1min
Azitra (AZTR.US
ATR-04 is in development for epidermal growth factor receptor inhibitor (EGFRi)-induced dermal toxicity, which affects approximately 150,000 patients in the US
Reduces methicillin-resistant S. aureus by 99% on ex vivo pig skin
Reduces IL-36g, a pro-inflammatory cytokine that drives inflammation in EGFRi-induced toxicity, in human skin model by 75% compared to erlotinib-treated skin
Increases human beta defensin 18-fold vs. vehicle on human skin model
Benzinga· 37 mins ago1min
Azitra (AZTR.US
ATR-04 is in development for epidermal growth factor receptor inhibitor (EGFRi)-induced dermal toxicity, which affects approximately 150,000 patients in the US
Reduces methicillin-resistant S. aureus by 99% on ex vivo pig skin
Reduces IL-36g, a pro-inflammatory cytokine that drives inflammation in EGFRi-induced toxicity, in human skin model by 75% compared to erlotinib-treated skin
Increases human beta defensin 18-fold vs. vehicle on human skin model
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
744Followers
75Following
4796Visitors
Follow